Science Sccess Scroll For Details
ABSTRACT SUBMISSION
REGISTRATION
abstractsubmission Abstract Submission Opens: August 09, 2019 | Welcome Message
Theme : New Advances and Research in Digestive disorders and Liver Cancer

ABOUT CONFERENCE

We welcome you and appreciate your participation at the Annual Congress On Digestive disorders and Liver Cancer and will be held during March 25-26,2020 in London, UK and will be organized around the theme of ” New Advances and Research in Digestive disorders and Liver Cancer” 
ACDL 2020 will be operated by world-class experts in the field of Digestive disorders and Liver Cancer, International symposiums, B2B meetings, workshops will also be organized to discuss the specific topics in the field of Gene Expression in Liver, Clinical Digestive disorders, Neuro- Digestive disorders, Cellular and Molecular Digestive disorders and Liver Cancer, Neurogastroenterology and Motility, Liver fibrosis, Neuro gastroenterology and Motility and many more. ACDL 2020 will take place in the city of London, UK on March 25-26,2020 with the theme of “Current trends in the field of Digestive disorders and Liver Cancer”. ACDL 2020 is designed to update health care providers practicing in Digestive disorders and Liver Cancer about new approaches to the diagnosis and management of Digestive disorders and liver diseases. Faculty will present data on multiple topics including general Digestive disorders, inflammatory bowel disease, colorectal neoplasia, esophageal diseases, motility, nutrition, pancreatic biliary disorders, endoscopy and hepatology. Digestive disorders is the study of the normal function and diseases of the esophagus, stomach, small intestine, colon and rectum, pancreas, gallbladder, bile ducts and liver. ACDL 2020 has over 16 tracks designed to update physicians, nurse practitioners, physician assistants and other healthcare providers practicing in Digestive disorders and Liver Cancer. About new approaches to the diagnosis and management of Digestive disorders and Liver Cancer. Speakers will present data on multiple topics including general gastroenterology, inflammatory bowel disease, immunology and bariatric surgery, gastrointestinal bleeding, disorders. 
ACDL 2020 is considered as one of the major conferences that provides best platform for attendees to acknowledge and learn recent trends and advancements in field of Digestive disorders and Liver Cancer research and development. This stream of conference deals with the internal organs which help in digestion of the organic or inorganic food materials. Digestive disorders and Liver Cancer conferences showcase the discussion topics confronting the functioning of esophagus, pancreas, gallbladder, bile ducts, liver, stomach, small intestine, colon, and rectum. Business networking is an avenue for vendors to have network and B2B meetings with “Top scientists and colleagues” and with an effective low cost marketing method for developing sales and opportunities and contacts, based on referrals and introductions either face-to-face at meetings and gatherings, or by other contact methods such as Telephone, E mail, Digital and Increasingly social and business networking websites.
 Why to attend? 
 ACDL 2020 will bring together experts like Gastroenterologists ,Clinicians Gastroenterologists, Hepatologists, Psychiatrists, Medical practitioners, Care specialists, academic professionals and students from all over the world to share an interest in the genetic pathways underlying Gastroenterology disorders, techniques to identify those genetic pathways, and the use of genetics and genomics as tools to develop therapeutics. The aim of the conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology. 
Target Audience: 
Endoscopy specialists
Hepatologists 
Gastro surgeons 
Clinical researchers and scientists 
Specialists Researchers and Scholars 
Health care professionals doctors
Medical and Health care Organizations
Associations and Medical Practitioners, 
Professors and Deans
Students and Technicians 
 Gene Expression in Liver 
There is a higher genetic diversity in tumor cells which holds at the gene expression level. Through knowing the gene expression level we can regulate the hepatocellular carcinoma during hepatitis viral infection. Disease progression in HBV and HCV induced can influence by both environmental factors and genetic risk factors. Nucleic acid-mediated gene therapy has been undergoing clinical trials which may result in the prevention of chronic liver diseases by regulating mechanisms of different proteins expression using miRNA overexpression and miRNA functional silencing. 
Sub Tracks: 
eQTL 
microarray 
liver 
Mouse 
Relevant societies:
 European Crohns and Colitis Organization Gastroenterohepatology 
 Association of Montenegro - GAM 
 The Australian and New Zealand Gastric and Oesophageal 
 Asian Pacific Association of Gastroenterology (APAGE) 
 Ukrainian Association of Endoscopy 
 Cellular and Molecular Gastroenterology and Hepatology 
Medical doctors and basic scientists working in the field of hepatology and to contribute to the improvement of public health through a multidisciplinary approach by sharing advanced basic and clinical research results for various diseases of the liver and biliary tract. The journal presents up-to-date coverage of basic and clinical researches on molecular and cell biology, pathophysiology, epidemiology, diagnosis, and treatment of the various diseases of the liver and biliary tract, with special attention to more common liver diseases of the Asian-Pacific region such as B viral hepatitis and hepatocellular carcinoma (HCC). Idiosyncratic drug-induced liver injury (DILI) is a rare adverse drug reaction and it can lead to jaundice, liver failure, or even death. Antimicrobials and herbal and dietary supplements are among the most common therapeutic classes to cause DILI in the Western world. Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. 
Sub Tracks:
Liver fibrosis
Fibro genesis 
My fibroblast 
Extracellular matrix
Relevant societies: 
Major Gastroenterology Societies around the Globe, 
Gastroenterological Society of Australia, 
European Society of Gastrointestinal Endoscopy (ESGE) , 
European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN). 
 Hepato Cardiac and Pulmonary Disorders 
Hepato-cardiac disorders are defined as a liver disease affecting the heart or the heart disease affecting the liver or the condition affecting heart and liver at the same time. During the Differential diagnosis of liver injury or disease, in a cardiologist, clinical practice, ask for collaboration between the hepatologists and cardiologists. In patients with advanced liver disease may show and various abnormalities like some diastolic and systolic dysfunctions, reduced cardiac performance. Cardiac evaluation in liver disease patients is important, after liver transplantation may improve cardiac function or have a reversal effect. Systemic disease with effect liver and heart are congenital, inflammatory and metabolic and alcoholism. The Hepato-pulmonary disorder which causes low oxygen levels in your blood is associated due to the formation of microscopic intrapulmonary arteriovenous dilations occurring in patients with liver cirrhosis. The mechanism is obscure due to increased hepatic production or decreased hepatic clearance of vasodilators. Due to the over perfusion related to ventilation, causes vascular dilations especially in increased cardiac yield individuals with resulting from systemic vasodilation and people having low oxygen levels in the blood encounter shortness of breath, which can become more severe over time. 
Sub Tracks: 
 Ischemic hepatitis
 Fatty liver
 Liver cirrhosis  
Heart failure 
Relevant societies: 
European society of Neuogastroenterology and Motility
United European Gastroenterology 
 Canadian Association of Gastroenterology (CAG)
Endoscopy and Nutrition 
 Hepato Nephrology and Hepatic Pathology 
Liver pathology is altered in HRS while kidney histology is normal. It is a trichrome stain (chicken wire appearance) cirrhosis of the liver, the most common cause of HRS. The diagnosis of hepatorenal syndrome is based on laboratory tests of individuals susceptible to the condition. Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dialysis, can prevent the advancement of the condition HRS can affect individuals with cirrhosis, severe alcoholic hepatitis, or liver failure, and usually occurs when liver function deteriorates rapidly because of a sudden insult such as an infection, bleeding in the gastrointestinal tract, or overuse of diuretic medications. 
Sub Tracks: 
Biopsy needle 
Kidney biopsy 
Ultrasound 
Relevant societies: 
Association of Gastroenterologists of Bosnia and Herzegovina
United European Gastroenterology 
 Canadian Association of Gastroenterology (CAG)
 European Association for Gastroenterology, Endoscopy, and Nutrition
 Hepatitis and its Types 
Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis. There are 5 main hepatitis viruses, referred to as types Hepatitis A (HAV), Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis D (HDV) and Hepatitis E (HEV). These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer. 
Sub Tracks: 
Autoimmune hepatitis 
Alcoholic hepatitis 
Viral Hepatitis 
Granulomatous hepatitis 
Relevant societies: 
The Japanese Gastroenterological Association (JGA) 
Association of Gastroenterologists of Bosnia and Herzegovina 
Liver Biopsy 
A liver biopsy is a procedure in which a small needle is inserted into the liver to collect a tissue sample. This is performed as an office or outpatient procedure or during surgery. The tissue is then analyzed in a laboratory to help doctors diagnose a variety of diseases and disorders in the liver. In most instances, there are no complications in obtaining a liver biopsy. However, rarely internal bleeding may occur, as well as a leak of bile from the liver or gallbladder. 
Sub Tracks: 
Percutaneous liver biopsy 
 Laparoscopic liver biopsy
Relevant societies: 
European Crohns and Colitis Organization
Gastroenterohepatology Association of Montenegro – GAM
Gastric and Oesophageal Surgery Association (ANZGOSA)
Asian Pacific Association of Gastroenterology (APAGE)
Ukrainian Association of Endoscopy 
Stem Cell Treatment 
Cell therapy is an emerging approach being tested in this setting. Hepatocytes are the principal cells of the liver parenchyma and are responsible for maintaining liver function. They can originate from three sources. In a normal liver, hepatocytes themselves can proliferate to restore the functional liver mass, a mechanism that could be compromised in cirrhosis. Second, the liver contains liver progenitor cells that can also proliferate and differentiate into hepatocytes. However, in some circumstances, this differentiation does not occur. Finally, blood-derived stem cells can infiltrate the liver and become hepatocytes, although the participation of this process in liver regeneration is poorly understood. Chronic liver diseases can lead to cirrhosis, characterized by fibrous septa dissecting the liver parenchyma, affecting both liver function (due to reduced functional mass) and normal intrahepatic venous pressure (due to increased stiffness). Antiviral treatment for hepatitis B or C virus infection, alcohol abstinence for alcohol-related liver disease, or weight loss strategies for metabolic non-alcoholic fatty liver disease, whereas other causes remain difficult to treat (like genetic disorders or autoimmune problems). Despite existing strategies, some patients still progress towards end-stage liver disease and its associated complications, including ascites, peritonitis, variceal bleeding, or hepatocellular carcinoma. No treatment is available to specifically target fibrosis and cirrhosis, and liver transplantation remains the only curative option. To avoid progression towards end-stage liver disease ultimately requiring rescue transplantation—which is not devoid of disadvantages (donor organ shortage, challenging surgery, and lifelong immunosuppression)—many researchers are investigating strategies to restore liver functionality. 
Sub Tracks: 
 Differentiation of Hepatocytes
Biochemistry in Liver Development 
 Transplantation of Cells 
Relevant societies: 
Major Gastroenterology Societies around the Globe
Gastroenterological Society of Australia 
European Society of Gastrointestinal Endoscopy (ESGE)
 European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN)
Pediatric and Geriatric Hepatology 
Liver diseases are mostly seen in a grown-up, however, a huge number of children from babies to teens experience from different types of liver diseases. The volume of the liver and the blood flow decreases with age, immune responses against pathogens or neoplastic cells are lower in the elderly reducing their tolerability to treatments for liver diseases. Liver regeneration capacity shows a decline in age, reduced proliferation of hepatocytes, but the level of hepatic enzymes and high-density lipoprotein cholesterol is well maintained. Pediatric hepatology focuses on the diagnosis and treatment of liver and liver-related disease in children. 
Sub Tracks: 
Acute Liver injury and Liver Regeneration
Liver fibrosis
Auto Immune Hepatitis 
Relevant societies: 
European society of Neuogastroenterology and Motility 
United European Gastroenterology
European Association for Gastroenterology 
Endoscopy and Nutrition  
The Japanese Gastroenterological Association (JGA)
Obesity or Bariatric Surgery 
Obesity has become a global health problem that contributes to numerous life-threatening and disabling diseases, such as type 2 diabetes mellitus and coronary artery disease. Bariatric surgery (weight loss surgery) is the technique used to treat obese person. The U.S. National Institutes of Health prescribes bariatric surgery for corpulent individuals with a body mass record (BMI) of no less than 40, and for individuals with BMI of no less than 35 and genuine coinciding therapeutic conditions. 
Sub Tracks: 
 Bariatric surgery
Eating-related behaviors
 Dietary supplements 
Relevant societies: 
IGA - Israel Gastroenterology Association 
Association of Gastroenterologists of Bosnia and Herzegovina 
 Canadian Association of Gastroenterology (CAG) 
European Association for Gastroenterology 
Endoscopy and Nutrition
Intestinal Rehabilitation 
Intestinal Rehabilitation deals with the process of restoring enteral autonomy and thus allowing freedom from parenteral nutrition usually by means of dietary, medical and occasionally surgical strategies. Intestinal rehabilitation occurs as a consequence of enhanced bowel adaptation or short bowel syndrome. A coordinated team of gastroenterologists, surgeons and nutritionists provide long-term care to Patients with short or malformed intestines. 
Sub Tracks: 
 Stroke 
 Hip fracture
Hospital-associated deconditioning 
Sarcopenic dysphagia 
Relevant societies: 
 IGA - Israel Gastroenterology Association 
Association of Gastroenterologists of Bosnia and Herzegovina
Treatment Advances in Digestive Diseases 
Helicobacter pylori (H. pylori) infection is a typical infection which will raise the peptic ulcers disease and gastric cancer. Most people with H. pylori infection will not have any signs and symptoms. Diagnosis can be done using blood test, breath test, stool test, scope test. Treatment can be done using Proton pump inhibitors, Histamine (H-2) blockers, Bismuth subsalicylate. Non-steroidal anti-inflammatory drugs (NSAIDs) are most widely used drugs and their widespread use is associated with increased gastro-intestinal toxic effects such as ulceration, haemorrhage, perforation and death. 
Sub Tracks: 
Body mass index
Digestive function
 Eating pattern
Sasang typology
 Type-specific pathophysiological symptoms 
Relevant societies: 
European Crohns and Colitis Organization 
Gastroenterohepatology Association of Montenegro – GAM 
The Australian and New Zealand Gastric and Oesophageal Surgery Association (ANZGOSA) 
Asian Pacific Association of Gastroenterology (APAGE)
 Ukrainian Association of Endoscopy 
Gastrointestinal Oncology 
Digestive cancers can have wide-ranging effects on nutritional status, health, and quality of life. It shows the symptoms of internal bleeding, acute pains, swelling, inability to digest, difficulty in swallowing or chronic constipation or acute diarrhea. The diagnosis often requires endoscopy, pursued by biopsy of doubtful tissue. The treatment depends upon the tumour location, as well as the type of cancer cell and whether it has invaded other tissues or spread elsewhere, these factors also determine the prognosis. Esophageal cancer is the 6th common cancer in the world, and its number is increasing. 
Sub Tracks: 
Sarcopenia 
Adenocarcinoma 
 Complications, Survival 
Relevant societies: 
Gastroenterological Society of Australia 
British society of Gastroenterology 
European Society of Gastrointestinal Endoscopy (ESGE)
 European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) 
Diabetic Ketoacidosis 
It is a life threatening problem and needs awareness about its prevention. It occurs when body doesn’t produce enough insulin and body cells can’t use sugar in blood for energy then body start using fat as fuel for energy. When the body continue to burn fat, it makes acids called ketones. If this process remains continue for a period of time, it will build up in body and can change the chemical balance of body and will affect the whole body functions. It is seen more in young ones having type 1diabetes. 
Sub Tracks: 
Diabetes 
Insulin
Rehydration
Hypoglycemia
Hypokalemia
Metabolic acidosis
Protocol 
Relevant societies:
European society of Neuogastroenterology and Motility
United European Gastroenterology
Canadian Association of Gastroenterology (CAG)
European Association for Gastroenterology
Endoscopy and Nutrition
 The Japanese Gastroenterological Association (JGA)
 Gastrointestinal Endoscopy 
Gastrointestinal endoscopy is a technique that enables your specialist to take a gander at within covering of your throat your stomach, and the initial segment of your small digestive tract. A thin, adaptable review apparatus called an endoscope (scope) is utilized. The tip of the extension is embedded through your mouth and after that tenderly moved down your throat into the throat, stomach and duodenum (upper gastrointestinal tract). In patients with OGIB, upper and lower GI tract endoscopies regularly are rehashed before little gut assessment because significant starting endoscopic miss rates have been accounted for. 
 Sub Tracks: 
Clinical endoscopy
Demonstrative Endoscopy
Colonoscopy and Sigmoidoscopy 
Endoscopic Methods
Advances in Endoscopy
Liver Cirrhosis
Relevant societies: 
European society of Neuogastroenterology and Motility 
United European Gastroenterology 
European Association for Gastroenterology 
Endoscopy and Nutrition
 The Japanese Gastroenterological Association (JGA)
Inflammatory Bowel Disease 
Inflammatory bowel disease (IBD) represents a group of intestinal disorders that cause prolonged inflammation of the digestive tract. The digestive tract comprises the mouth, oesophagus, stomach, small intestine, and large intestine. It’s responsible for breaking down food, extracting the nutrients, and removing any unusable material and waste products. Inflammation anywhere along the digestive tract disrupts this normal process. IBD can be very painful and disruptive, and in some cases, it may even be life-threatening. 
Sub Tracks: 
 Health literacy 
 Inflammatory bowel disease
 Knowledge translation
 Ulcerative colitis 
Relevant societies: 
European society of Neuogastroenterology and Motility
United European Gastroenterology
Canadian Association of Gastroenterology (CAG)
Endoscopy and Nutrition 
 The Japanese Gastroenterological Association (JGA) 
Colorectal Diseases (CRD) 
Varies from benign lesions to malignant and cancerous masses. Several tests and procedures to screen and diagnose colorectal disease, including one or more of the following Colonoscopy, flexible Sigmoidoscopy, Endoscopic ultrasound, Capsule endoscopy. Various medical and surgical treatment options for colorectal disease, including: Endoscopic mucosal resection, fecal micro biota transplant, Bowel resection, J-pouch surgery. Sub Tracks: 
Early detection of cancer 
 Colorectal neoplasms 
 Colonoscopy 
 Computed tomographic colonography 
Relevant societies: 
European Crohns and Colitis Organization 
Gastroenterohepatology Association of Montenegro – GAM 
The Australian and New Zealand Gastric and Oesophageal Surgery Association (ANZGOSA) 
Asian Pacific Association of Gastroenterology (APAGE) 
 Ukrainian Association of Endoscopy
Read More

SCIENTIFIC SESSIONS

MARKET RESEARCH


Metabolism is a process in which human body generates energy from the food humans eat. The food that humans consume comprises proteins, carbohydrates, and fats. Chemicals in human digestive system break the food parts down into sugars and acids. Metabolic disorders occur when abnormal chemical reactions in human body disturb this process. This is due to enzyme deficiency: as all processes in the body are controlled by enzymes. Any disturbance in the pathways involved in the development and metabolism of carbohydrates, proteins, and fats, leads to metabolic disorder. While in 2015, the market size of metabolic disorder therapeutics was valued over USD XX million. The global metabolic disorder therapeutics market is projected to grow with a CAGR between 4.8% and 5.3% over the forecast period of 2018-2023 and reach USD 200 billion by 2023. 
      Metabolism is a process in which human body generates energy from the food humans eat. The food that humans consume comprises proteins, carbohydrates, and fats. This is due to enzyme deficiency as all processes in the body are controlled by enzymes. Any disturbance in the pathways involved in the development and metabolism of carbohydrates, proteins, and fats, leads to metabolic disorder. Increase in academia-industry collaborations for drug developments is the key factor responsible for the growth of metabolic disorder therapeutics market. Furthermore, growing diabetic population is significantly contributing to the growth of this market. Low compliance, adherence rate for metabolic disorder therapies and availability of alternative treatment option are the major challenges faced by the players operating in this market. The global metabolic disorder therapeutics market is anticipated to present several opportunities of growth of market size over the forecast period due to strategic collaborations and acquisition and increased R & D investment. Market Insights Increase in academia-industry collaborations for drug developments is the key factor responsible for the growth of metabolic disorder therapeutics market. Furthermore, growing diabetic population is significantly contributing to the growth of this market. Low compliance, adherence rate for metabolic disorder therapies and availability of alternative treatment option are the major challenges faced by the players operating in this market. The global metabolic disorder therapeutics market is anticipated to present several opportunities of growth of market size over the forecast period due to strategic collaborations and acquisition and increased R & D investment Segment Covered The report on global metabolic disorders therapeutics market covers segments such as, disease type and product. On the basis of disease type the global metabolic disorders therapeutics market is categorized into diabetes, obesity, hypercholesterolemia and lysosomal storage disease. On the basis of product the global metabolic disorders therapeutics market is categorized into metachromatic leukodystrophy, globoid leukodystrophy,hepatic encephalopathy and others. The report segments the metabolic disorder therapeutics market by types of disease and by region. Among segments given above; diabetes market is estimated to be 24.9 billion USD in 2017, it is growing because of the higher growth in the global type 2 diabetic population. The Oral Anti Diabetes Market is expected to witness a growth of about 28% from 2018 to 2023 and it is expected to reach USD 34.1 billion by 2023.
     The increasing diabetic population across the globe is one of the significant factors propelling the growth of this segment. Gastroenterology in America: Over the review period in America, the changing lifestyles of consumers resulted in a significant increase in dietary ailments that are reflected in the positive performance of digestive remedies. According to the market analysis, digestive disorders affect more than 20 million people each year. Inflammatory bowel disease (IBD), heartburn, acid reflux and irritable bowel syndrome (IBS) are among the most common digestive disorders. Gastroenterology in Asia: Though the Asia-Pacific market for probiotics is globally the largest, accounting for an estimated share of 38% in 2018, market maturity is expected to curtail growth prospects over the coming years, with other regions taking the lead. Within Asia-Pacific, Japan forms the largest probiotics market, with an estimated share of 45% in 2018. However, growth in demand for probiotics is likely to be the fastest in China, with a forecast CAGR of about 13.2% between 2017 and 2023. By segment, human applications such as dietary supplements, functional foods & beverages and specialty nutrients dominate the probiotics market in the region. expected to grow at a CAGR of 6.6% over the forecast period.

WHY TO ATTEND?


This event acts as great platform to exchange knowledge and get updated to recent researches in respective field. This event will provide an opportunity to build and expand your network with various people and gives chance to make collaboration with other universities and research labs. It also helps you to meet the experts in the relevant field of study. This conference plays a major role in your business development and maximizes the profit. The aim of the conference is to provide the professionals and academicians from various branches to debate and deliberate on social change that is encompassed by innovation and technology.


WHY CHOOSE US

WHY CHOOSE US


  • Scietech International is initiated to meet a need or to pursue collective goals of the scientific community, especially in exchanging the ideas which facilitate growth of research and development.
  • We specialize in organizing conferences, meetings and workshops internationally to overcome the problem of good and direct communication between scientists, researchers working in same fields or in interdisciplinary research.
  • Scietech Group promotes open discussions and free exchange of ideas at the research frontiers mainly focusing on science field.
  • Intense discussions and examination based on professional interests will be an added advantage for the scientists and helps them learn most advanced aspects of their field.
  • It proves that these conferences provide a technique for valuable means of disseminating information and ideas that cannot be achieved by usual channels of communications.
  • To encourage an informal community atmosphere usually we select conference venues which are chosen partly for their scenic and often isolated nature.
  • In sinuations from many scientists and their reviews on our conferences reflected us to continue organizing annual conferences globally.
  • The conference proceedings are regularly publicized in respective journals and details of such proceedings are displayed in the individual conference website.

Organizing Committee

Eda Alemdar
Full Details

Eda Alemdar

Faculty of Medicine in Macedonia.
Dr Sumita A. Jain
Full Details

Dr Sumita A. Jain

Head, Department of Surgery S.M.S Medical College,INDIA
Rosa Lelyana
Full Details

Rosa Lelyana

Medicine Faculty of Diponegoro University,Indonesia
Dr.Shuxin Han
Full Details

Dr.Shuxin Han

Head of Central Nodal Bioscience and Technology Research Center

Target Audience

Gastroenterologists 
 Endoscopy specialists 
 Hepatologists Gastro surgens 
 Clinical researchers and scientists 
 Specialists Researchers and Scholars 
 Health care professionals Doctors 
 Medical and Health care Organizations 
 Associations and Medical Practioners 
 Professors and Deans Students and Technicians 
 Allied Health Professionals with an interest in Gastroenterology 
 Anesthesiologists 
 Family Practitioners 
 Advanced Endoscopy Fellows 
 Enterprenuers 
 Obesity Specialist 
 Radiologists 
 Medical Equipment Manufacturers

Don’t Miss This Event

Great Event Schedule

Time Session
09:00-09:15 Registrations
09:15-09:30 Keynote Forum Opening Ceremony
09:30-11:30 Session Keynote Forum
11:30-11:45 Networking and Refreshment Break
11:45-13:00 Sessions
13:00-13:40 Lunch Break
13:40-15:30 Sessions
15:30-15:45 Networking and Refreshment Break
15:45-17:45 Sessions
17:45-18:00 Panel Discussion
Time Session
9:15-10:45 Keynote Forum
10:45-11:15 Networking and Refreshment Break
11:15-13:00 Sessions
13:00-13:45 Lunch Break
13:45-15:30 Sessions
15:30-15:45 Networking and Refreshment Break
15:45-17:00 Poster Presentations and Panel Discussion
Time Session
Time Session

Frequently Asked Questions

Didn’t Find Yet? Ask Your Question

Media Partners